Not medical advice. I am a software engineer, not a physician. This page documents my own protocol and the research I read while building it. Talk to a qualified clinician before changing your supplementation, diet or any treatment. Lab reference ranges quoted here vary by laboratory and by individual.
Affiliate disclosure: the iHerb links on this page carry a referral code and pay me a commission if you buy. It does not change your price, and I do not link anything I do not use myself.
The liver performs over 500 functions, making it arguably the most metabolically complex organ in the body. It filters 1.4 liters of blood per minute, detoxifies drugs, alcohol, and environmental toxins, synthesizes bile for fat digestion, produces albumin and clotting factors, regulates blood sugar via glycogen storage, and converts ammonia to urea. When the liver is overwhelmed — by chronic alcohol use, medication burden, processed food, or environmental toxins — its detoxification capacity degrades, leading to elevated liver enzymes, fatigue, impaired fat metabolism, and eventually fatty liver disease (NAFLD), which now affects roughly 25% of the global population.
Key insight: Liver detoxification is not a marketing buzzword — it is a well-characterized two-phase biochemical process. Phase I converts fat-soluble toxins into reactive intermediates via cytochrome P450 enzymes. Phase II conjugates these intermediates with glutathione, sulfate, or glucuronic acid to make them water-soluble for excretion. If Phase II cannot keep pace with Phase I, the reactive intermediates accumulate and cause oxidative damage.
The cytochrome P450 enzyme family (primarily CYP1A2, CYP2D6, CYP3A4) catalyzes oxidation, reduction, and hydrolysis reactions that convert lipophilic compounds into more polar intermediates. These reactions expose or add functional groups (–OH, –NH2, –SH) that serve as handles for Phase II conjugation. However, the intermediates produced are often more reactive and toxic than the parent compound — this is why Phase II capacity is critical.
Phase II enzymes attach water-soluble molecules to the Phase I intermediates, making them safe for excretion via bile or urine. The most important conjugation pathway is glutathione conjugation, catalyzed by glutathione S-transferase (GST). Glutathione (GSH) is a tripeptide (glutamate-cysteine-glycine) and the body's master antioxidant. It neutralizes reactive oxygen species, regenerates vitamins C and E, and is consumed in massive quantities during detoxification. NAC (N-Acetyl Cysteine) is the rate-limiting precursor for glutathione synthesis: it provides the cysteine that is the bottleneck in GSH production.
Mokhtari, V., et al. (2017). A review on various uses of N-acetyl cysteine. Cell J, 19(1), 11-17. PMID: 34488802
Milk thistle extract (silymarin, composed primarily of silybin) protects hepatocytes through multiple mechanisms: it stabilizes cell membranes against toxin entry, stimulates ribosomal RNA polymerase to increase protein synthesis (accelerating hepatocyte regeneration), scavenges free radicals, and inhibits NF-kB-mediated inflammatory signaling. A systematic review by Saller et al. (2008) found that silymarin reduced liver-related mortality in patients with alcoholic liver disease and improved liver function markers (ALT, AST) across multiple trials.
Saller, R., et al. (2008). An updated systematic review of the pharmacology of silymarin. Forsch Komplementmed, 15(1), 9-20. PMID: 20564545
The following supplements target liver protection, glutathione synthesis, and anti-inflammatory pathways. For full dosing and timing details, see the Supplement Stack article.
| Supplement | Role | Timing | Link |
|---|---|---|---|
| NAC (N-Acetyl Cysteine) | Rate-limiting glutathione precursor; replenishes hepatic GSH stores depleted by toxins, medications, and oxidative stress | 3x/day (fasted AM, lunch, dinner) | Stack → |
| Milk Thistle (Silymarin) | Hepatocyte membrane stabilizer, stimulates liver cell regeneration, inhibits NF-kB inflammatory cascade | With meals (2–3x/day) | Stack → |
| Curcumin (Turmeric extract) | Potent NF-kB inhibitor, reduces hepatic inflammation, enhances bile flow (choleretic effect) | With breakfast (with fat for absorption) | Stack → |
| Vitamin C | Antioxidant cofactor, regenerates glutathione from its oxidized form (GSSG → GSH), supports Phase I enzymes | With breakfast | Stack → |
NAC and kidney clearance: NAC and its metabolites are renally cleared. If you take NAC 3x/day (a common protocol for glutathione optimization), monitor kidney function (creatinine, BUN, GFR) at least annually. Reduce dosing frequency if GFR drops below 60 mL/min. Always stay well-hydrated when taking NAC.
The NAC + Vitamin C synergy: NAC provides the cysteine for new glutathione synthesis, while Vitamin C recycles oxidized glutathione (GSSG) back to its active reduced form (GSH). Taking both together maximizes the glutathione pool — both production and recycling.
Aggarwal, B. B., & Sung, B. (2009). Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends Pharmacol Sci, 30(2), 85-94. PMID: 17569207
Liver damage is often asymptomatic until advanced stages. Regular lab monitoring catches problems early. These tests also serve as feedback for your supplement protocol — if liver enzymes improve, the protocol is working. See the Preventive Lab Tests guide for complete reference ranges.
| Test | What It Measures | Frequency | Link |
|---|---|---|---|
| Liver Panel (AST, ALT, GGT) | AST and ALT are enzymes released when hepatocytes are damaged. GGT is elevated by alcohol, medications, and bile duct obstruction. ALT is more liver-specific than AST. | Every 6 months | Details → |
| CRP (C-Reactive Protein) | Systemic inflammation marker — liver-driven inflammation from NAFLD or toxic burden elevates CRP. Also monitors curcumin's anti-inflammatory effect. | Every 6 months | Details → |
| Kidney Panel (Creatinine, BUN, GFR) | Monitors renal clearance capacity — critical when taking NAC 3x/day, as NAC metabolites are renally excreted. GFR below 60 requires dose adjustment. | Annually | Details → |
Interpreting liver enzymes: Ideal ALT is below 25 U/L for men and 22 U/L for women (stricter than most lab reference ranges that go up to 40–56). If ALT is above 30 U/L, investigate causes: alcohol, medications (acetaminophen, statins), fatty liver, or viral hepatitis. NAC + milk thistle often bring mild elevations back to optimal within 2–3 months.
The most significant liver health development in 2023-2025 is the official adoption of MASLD (Metabolic dysfunction-Associated Steatotic Liver Disease) as the replacement for NAFLD (Non-Alcoholic Fatty Liver Disease). This terminology shift, endorsed by AASLD, EASL, EASD, and EASO, changes the diagnostic framework from exclusion-based (no alcohol) to inclusion-based (at least one cardiometabolic risk factor plus hepatic steatosis). MASH replaces NASH. The 2025 EASL-EASD-EASO Clinical Practice Guidelines provide updated diagnostic and treatment algorithms, and the Korean (KASL) and Indian (INASL) liver associations have adopted the new nomenclature in their 2025 guidelines. A June 2025 ADA consensus report specifically addressed MASLD screening in people with diabetes, recommending liver enzyme panels combined with FIB-4 scoring for at-risk adults.
Clinically, this means if your lab work shows elevated ALT alongside any metabolic risk factor (obesity, insulin resistance, hypertension, dyslipidemia, or elevated fasting glucose), the diagnosis is now MASLD rather than NAFLD. The practical implications for patients are minimal, but the updated criteria enable earlier identification and intervention.
AASLD (2023-2025). New MASLD Nomenclature. AASLD